welbournes

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets. MSN/2023/048 Tier 2 – medium impact Date of issue 24th April 2023 Oxybutynin 5mg modified-release tablets are out of stock until w/c 1st May 2023. Oxybutynin immediate release formulations (tablets and liquid) remain available and can support [...]

The post Medicine Supply Notification: Oxybutynin 5mg modified-release tablets appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has today (21/04/2023) granted the following list of price concessions for April 2023: Drug Pack size Price concession Bicalutamide 150mg tablets 28 £3.99 Bisacodyl 5mg gastro-resistant tablets 60 £4.99 Bisoprolol 2.5mg tablets 28 £1.02 Cinacalcet 30mg tablets 28 £11.95 Clarithromycin 250mg/5ml oral suspension 70 £5.50 Clotrimazole 1% [...]

The post April Price Concessions 2nd Update appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has today (18/04/2023) granted the following initial list of price concessions for April 2023: Drug Pack size Price concession Amisulpride 100mg tablets 60 £20.29 Amisulpride 50mg tablets 60 £13.09 Amoxicillin 250mg/5ml oral suspension 100 £4.01 Amoxicillin 250mg/5ml oral suspension sugar free 100 £3.50 Amoxicillin 500mg capsules 15 [...]

The post April 2023 Price Concessions 1st Update appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol (Estradot®) 75micrograms/24hours transdermal patches. MSN/2023/047 Tier 2 – medium impact Date of issue 13th April 2023 Estradiol (Estradot®) 75micrograms/24hours transdermal patches are out of stock until early May 2023. An alternative brand of estradiol patches, Evorel®, available as 75micrograms/24hours can [...]

The post Medicine Supply Notification: Estradiol (Estradot® ) 75micrograms/24hours transdermal patches appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Alfuzosin 10mg modified release tablets. MSN/2023/045 Tier 2 – medium impact Date of issue 12th April 2023 There is limited supply of alfuzosin 10mg modified release tablets until w/c 15th May 2023. Alternative alpha-adrenoceptor blockers licensed for the symptomatic treatment of [...]

The post Medicine Supply Notification: Alfuzosin 10mg modified release tablets appeared first on PSNC Website.